Best Shopping Centers in Brazil

© 2012 BlogName - All rights reserved.

Firstyme WordPress Theme.
Designed by Charlie Asemota.

Seattle Genetics Founder Clay Sieggal Talks Medical Breakthroughs On His Blog

March 31, 2017 - Author: steph

Clay Siegall is the current President, COO, and CEO of Seattle Genetics. His pharmaceutical firm which has successfully developed safe and effective antibody-drug conjugates (ADC’s). ADC’s like ADCETRIS, are designed to attack and kill the cancer cells specifically. Dr. Clay’s WordPress site recently published a medical blog post titled, ‘Paralyzed Man Uses Thoughts to Control His Own Arm And Hand.’ The topic drew in our attention especially with all the talk on the news recently about the future of medicine powered by technology.

Elon Musk’s Vision

Billionaire investors led by Tesla Inc. Owner and CEO, Elon Musk have poured an infinite amount of funding towards combining man and machine. All for the betterment of humanity faced by deadly scourges such as cancer. Again, not to digress much, the story on the blog talked about a man who had lost all control of his arms following a car accident. For the next eight years, the 56-year-old Bill Kochevar would remain confined to a wheelchair.

Rethinking Possible

Technology, fortunately, came to his rescue and aid and he could use his arms once more, thanks to robotic sensor technology. In a nutshell, the technology works with the help of advanced algorithms, robotic arms, and electrodes. Impulses are transferred from the patient’s mind via the skill to the arm muscles. Corresponding algorithms lead to particular movement, and there you have it. Yay! Disability no more.

Have You Had an HPV Shot?

In another interesting post, the reader gets introduced to a research findings controversy trending among the leading global oncologists. HPV is a deadly scourge currently estimated to affect 26,000 women in the U.S alone. Researchers are quoted advocating for the use of HPV vaccines to prevent not only the usual culprit; STI’s, rather prevent a long list of other cancers out there.

Dr. Clay’s Role at Seattle Genetics

Asides being one of the co-founders, Clay Siegall is in charge of the day to day decision-making the process of Seattle Genetics. The B.S Zoology graduate of the University of Maryland plays an active hands-on role in the development of the drugs and vaccines they have in the works. He attained his Ph.D. from the esteemed George Washington University.

No Comments - Categories: Genetics

Clay Siegall’s Passion And Leadership Is The Equation Creating Seattle Genetics’ Success

February 28, 2017 - Author: steph


With many companies now in the business of the cancer field, it can be hard to differentiate between them. Seattle Genetics however is one of the more interesting of these companies, focused on creating innovative technology to advance cancer therapies. Their success can easily be seen in the tripling of their stock price in the last 5 years.

Behind the helm is CEO, Clay Siegall. Since the beginning of his career, Dr. Siegall has had a deep passion for improving the lives of cancer patients. He founded Seattle Genetics in 1998, working tirelessly ever since then to create amazing advancements in cancer research and innovative therapies for those patients.

After receiving his Ph.D. from George Washington University, Dr. Siegall has become an accomplished scientist. He has worked as a Senior Research Investigator and Principal Scientist at Bristol-Myers Squibb Pharmaceutical Research Institute and a Staff Fellow at the National Cancer Institute. It was after these positions that he moved on to create Seattle Genetics.

Clay Siegall has been committed to important cancer research. His true desire to help patients has guided him to become one of the foremost leaders in the cancer research field. Seattle Genetics has reached new levels of research advancements, developing the first antibody-drug conjugates (ADCs) that have received FDA approval. ADCETRIS was their first ADC, now expanding its impact all over the world to over 60 countries. Dr. Siegall’s passion and perseverance is evident by his assurance of FDA approval for ADCETRIS and his steadfast commitment to ensuring the drug is available to as many patients around the world as possible.

Aside from being a brilliant scientist and passionate member of society, Clay Siegall is also known for his leadership in fundraising abilities. He has personally secured over $1.2 billion in both private and public funding for Seattle Genetics for its endeavors. His perfect blend of scientific know-how and leadership skills have attributed to Seattle Genetics’ brilliant success.

Dr. Siegall has received many awards for his leadership and scientific abilities. In 2012, he was named the Pacific Northwest Ernst &Young Entrepreneur of the Year. In 2013, he became the University of Maryland’s Alumnus of the Year for Computer, Math and Natural Sciences.

No Comments - Categories: Genetics